Literature DB >> 9174049

Dissociation between cell cycle arrest and apoptosis can occur in Li-Fraumeni cells heterozygous for p53 gene mutations.

D Delia1, K Goi, S Mizutani, T Yamada, A Aiello, E Fontanella, G Lamorte, S Iwata, C Ishioka, S Krajewski, J C Reed, M A Pierotti.   

Abstract

The radiation response was investigated in two lymphoblastoid cell lines (LBC) derived from families with heterozygous germ-line missense mutations of p53 at codon 282 (LBC282) and 286 (LBC286), and compared to cells with wt/wt p53(LBC-N). By gel retardation assays, we show that p53-containing nuclear extracts from irradiated LBC282 and LBC286 markedly differ in their ability to bind to a p53 DNA consensus sequence, the former generating a shifted band whose intensity is 30-40% that of LBC-N, the latter generating an almost undetectable band. Unlike LBC286, which fail to arrest in G1 after irradiation, LBC282 have an apparently normal G1/S checkpoint, as they arrest in G1, like LBC-N. While in LBC-N, accumulation of p53 and transactivation of p21WAF1 increase rapidly and markedly by 3 h after exposure to gamma-radiation, in LBC286 there is only a modest accumulation of p53 and a significantly delayed and quantitatively reduced transactivation of p21WAF1. Instead, in LBC282 while p53 levels rise little after irradiation, p21WAF1 levels increase rapidly and significantly as in normal LBC. Apoptotic cells present 48 h after irradiation account for 32% in LBC-N, 8-9% in LBC282 and 5-7% in LBC286, while the dose of gamma-radiation required for killing 50% of cells (LD50) is 400 rads, 1190 rads and 3190 rads, respectively, hence indicating that the heterozygous mutations of p53 at codon 282 affects radioresistance and survival, but not the G1/S cell cycle control. In all LBC tested, radiation-induced apoptosis occurs in all phases of the cell cycle and appears not to directly involve changes in the levels of the apoptosis-associated proteins bcl-2, bax and mcl-1. Both basal as well as radiation-induced p53 and p21WAF1 proteins are detected by Western blotting of FACS-purified G1, S and G2/M fractions from the three cell lines. p34CDC2-Tyr15, the inactive form of p34CDC2 kinase phosphorylated on Tyr15, is found in S and G2/M fractions, but not in G1. However, 24 h after irradiation, its levels in these fractions diminish appreciably in LBC-N but not in the radioresistant LBC286 and LBC282. Concomitantly, p34CDC2 histone H1 kinase activity increases in the former, but not in the latter cell lines, hence suggesting a role for this protein in radiation-induced cell death. Altogether, this study shows that, in cells harbouring heterozygous mutations of p53, the G1 checkpoint is not necessarily disrupted, and this may be related to the endogenous p53 heterocomplexes having lost or not the capacity to bind DNA (and therefore transactivate target genes). Radiation-induced cell death is not cell cycle phase specific, does not involve the regulation of bcl-2, bax or mcl-1, but is associated with changes in the phosphorylation state and activation of p34CDC2 kinase.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9174049     DOI: 10.1038/sj.onc.1201050

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  12 in total

Review 1.  Genotype phenotype correlation in Li-Fraumeni syndrome kindreds and its implications for management.

Authors:  R N Moule; S G Jhavar; R A Eeles
Journal:  Fam Cancer       Date:  2006       Impact factor: 2.375

2.  Cyclin-mediated G1 arrest by celecoxib differs in low-versus high-grade bladder cancer.

Authors:  Jason R Gee; Corrie B Burmeister; Thomas C Havighurst; Kyungmann Kim
Journal:  Anticancer Res       Date:  2009-10       Impact factor: 2.480

3.  A novel p53-inducible gene coding for a microtubule-localized protein with G2-phase-specific expression.

Authors:  R Utrera; L Collavin; D Lazarević; D Delia; C Schneider
Journal:  EMBO J       Date:  1998-09-01       Impact factor: 11.598

4.  Human bone marrow stromal cells display variable anatomic site-dependent response and recovery from irradiation.

Authors:  Monika Damek-Poprawa; Derek Stefanik; Lawrence M Levin; Sunday O Akintoye
Journal:  Arch Oral Biol       Date:  2010-04-07       Impact factor: 2.633

5.  Targeted point mutations of p53 lead to dominant-negative inhibition of wild-type p53 function.

Authors:  Annemieke de Vries; Elsa R Flores; Barbara Miranda; Harn-Mei Hsieh; Conny Th M van Oostrom; Julien Sage; Tyler Jacks
Journal:  Proc Natl Acad Sci U S A       Date:  2002-02-26       Impact factor: 11.205

6.  The need for dynamic methods for measuring cell cycle perturbations: a study in radiation-treated lymphoblastoid cell lines of varying p53 status.

Authors:  R Gilchrist; M E Lomax; R S Camplejohn
Journal:  Cell Prolif       Date:  1999-02       Impact factor: 6.831

7.  Characterization of structural p53 mutants which show selective defects in apoptosis but not cell cycle arrest.

Authors:  K M Ryan; K H Vousden
Journal:  Mol Cell Biol       Date:  1998-07       Impact factor: 4.272

8.  DNA damage-induced cell cycle regulation and function of novel Chk2 phosphoresidues.

Authors:  Giacomo Buscemi; Luigi Carlessi; Laura Zannini; Sofia Lisanti; Enrico Fontanella; Silvana Canevari; Domenico Delia
Journal:  Mol Cell Biol       Date:  2006-08-28       Impact factor: 4.272

9.  Radio-induced malignancies after breast cancer postoperative radiotherapy in patients with Li-Fraumeni syndrome.

Authors:  Steve Heymann; Suzette Delaloge; Arslane Rahal; Olivier Caron; Thierry Frebourg; Lise Barreau; Corinne Pachet; Marie-Christine Mathieu; Hugo Marsiglia; Céline Bourgier
Journal:  Radiat Oncol       Date:  2010-11-08       Impact factor: 3.481

10.  ATM protein and p53-serine 15 phosphorylation in ataxia-telangiectasia (AT) patients and at heterozygotes.

Authors:  D Delia; S Mizutani; S Panigone; E Tagliabue; E Fontanella; M Asada; T Yamada; Y Taya; S Prudente; S Saviozzi; L Frati; M A Pierotti; L Chessa
Journal:  Br J Cancer       Date:  2000-06       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.